FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Artif Organs / Retinal and optic nerve diseases.
Artificial organs2003; 27(11); 963-974; doi: 10.1046/j.1525-1594.2003.07304.x

Retinal and optic nerve diseases.

Abstract: A variety of disease processes can affect the retina and/or the optic nerve, including vascular or ischemic disease, inflammatory or infectious disease, and degenerative disease. These disease processes may selectively damage certain parts of the retina or optic nerve, and the specific areas that are damaged may have implications for the design of potential therapeutic visual prosthetic devices. Outer retinal diseases include age-related macular degeneration, pathologic myopia, and retinitis pigmentosa. Although the retinal photoreceptors may be lost, the inner retina is relatively well-preserved in these diseases and may be a target for retinal prosthetic devices. Inner retinal diseases include retinal vascular diseases such as diabetic retinopathy, retinal venous occlusive disease, and retinopathy of prematurity. Other retinal diseases such as ocular infections (retinitis, endophthalmitis) may affect all retinal layers. Because the inner retinal cells, including the retinal ganglion cells, may be destroyed in these diseases (inner retinal or whole retinal), prosthetic devices that stimulate the inner retina may not be effective. Common optic nerve diseases include glaucoma, optic neuritis, and ischemic optic neuropathy. Because the ganglion cell nerve fibers themselves are damaged, visual prosthetics for these diseases will need to target more distal portions of the visual pathway, such as the visual cortex. Clearly, a sound understanding of retinal and optic nerve disease pathophysiology is critical for designing and choosing the optimal visual prosthetic device.
Get Full Text
Publication Date: 2003-11-18 PubMed ID: 14616515DOI: 10.1046/j.1525-1594.2003.07304.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on equine eye diseases affecting the retina and optic nerve. It emphasizes the importance of understanding the normal appearance and variations of the horse’s eye to recognise any abnormalities in the retina, optic nerve, and other parts. The study covers both congenital and acquired eye diseases in horses.

Understanding Equine Eye Anatomy

  • The main objective of this research is to equip equine specialists with the necessary knowledge and skills to examine the equine fundus – a section of the horse’s eye that includes the retina, choroid, optic nerve, and vitreous humor. These parts play a crucial role in the animal’s visual ability, and any disorder or abnormality can lead to significant vision problems.
  • Understanding the normal appearance and variations of the equine fundus is considered crucial. Knowing what is normal will help practitioners identify any deviations or changes that might signify a problem.

Evaluating Eye Abnormalities

  • Once a practitioner is familiar with the normal variations in equine eye anatomy, they can then assess any abnormalities that could arise in the retina, choroid, optic nerve, and vitreous humor. Any difference in the normal appearance of these sections of the eye might indicate eye disorders or diseases.
  • The research provides a comprehensive overview of the different types of abnormalities that can occur, guides on how to detect them, and the potential diseases they could signify.

Types of Equine Eye Diseases

  • The study further elaborates on the different diseases of the equine eye, which are classified as either congenital or acquired. Congenital diseases are those that the animal is born with, while acquired diseases are those that the animal gets throughout its life due to various causes such as injuries, infections, or age-related changes.
  • The researchers offer detailed discussions and illustrations to help practitioners diagnose these diseases. By understanding these types of diseases, equine ophthalmologists can provide more effective treatments and care for their equine patients.

Cite This Article

APA
Margalit E, Sadda SR. (2003). Retinal and optic nerve diseases. Artif Organs, 27(11), 963-974. https://doi.org/10.1046/j.1525-1594.2003.07304.x

Publication

Artificial organs
ISSN: 0160-564X
NlmUniqueID: 7802778
Country: United States
Language: English
Volume: 27
Issue: 11
Pages: 963-974

Researcher Affiliations

Margalit, Eyal
  • Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.
Sadda, Srinivas R

    MeSH Terms

    • Diabetic Retinopathy / therapy
    • Geniculate Bodies / physiology
    • Humans
    • Infant, Newborn
    • Optic Nerve / physiology
    • Optic Nerve Diseases / physiopathology
    • Optic Nerve Diseases / therapy
    • Optic Neuritis / therapy
    • Pigment Epithelium of Eye / cytology
    • Prostheses and Implants
    • Retinal Diseases / physiopathology
    • Retinal Diseases / therapy
    • Retinitis Pigmentosa / therapy
    • Retinopathy of Prematurity / therapy
    • Vision, Ocular / physiology

    References

    This article includes 69 references

    Citations

    This article has been cited 38 times.
    1. Kaya MK, Arslan S, Kaya S, Tasci G, Tasci B, Ozsoy F, Dogan S, Tuncer T. Self-AttentionNeXt: Exploring schizophrenic optical coherence tomography image detection investigations. World J Psychiatry 2025 Sep 19;15(9):108359.
      doi: 10.5498/wjp.v15.i9.108359pubmed: 40933157google scholar: lookup
    2. Power D, Elstrott J, Schallek J. Photoreceptor loss does not recruit neutrophils despite strong microglial activation. Elife 2025 Jul 22;13.
      doi: 10.7554/eLife.98662pubmed: 40694413google scholar: lookup
    3. Agbareia R, Omar M, Zloto O, Glicksberg BS, Nadkarni GN, Klang E. Multimodal LLMs for retinal disease diagnosis via OCT: few-shot versus single-shot learning. Ther Adv Ophthalmol 2025 Jan-Dec;17:25158414251340569.
      doi: 10.1177/25158414251340569pubmed: 40400723google scholar: lookup
    4. Khan SD, Basalamah S, Lbath A. A novel deep learning framework for retinal disease detection leveraging contextual and local features cues from retinal images. Med Biol Eng Comput 2025 Jul;63(7):2029-2046.
      doi: 10.1007/s11517-025-03314-0pubmed: 39918766google scholar: lookup
    5. Power D, Elstrott J, Schallek J. Photoreceptor loss does not recruit neutrophils despite strong microglial activation. bioRxiv 2025 May 29;.
      doi: 10.1101/2024.05.25.595864pubmed: 38854151google scholar: lookup
    6. Yu H, Shen B, Han R, Zhang Y, Xu S, Zhang Y, Guo Y, Huang P, Huang S, Zhong Y. CX3CL1-CX3CR1 axis protects retinal ganglion cells by inhibiting microglia activation in a distal optic nerve trauma model. Inflamm Regen 2024 Jun 6;44(1):30.
      doi: 10.1186/s41232-024-00343-4pubmed: 38844990google scholar: lookup
    7. Wei Q, Lin SM, Xu SH, Zou J, Chen J, Kang M, Hu JY, Liao XL, Wei H, Ling Q, Shao Y, Yu Y. Graph theoretical analysis and independent component analysis of diabetic optic neuropathy: A resting-state functional magnetic resonance imaging study. CNS Neurosci Ther 2024 Mar;30(3):e14579.
      doi: 10.1111/cns.14579pubmed: 38497532google scholar: lookup
    8. Soliño M, Larrayoz IM, López EM, Rey-Funes M, Bareiro M, Loidl CF, Girardi E, Caltana L, Brusco A, Martínez A, López-Costa JJ. CB1 Cannabinoid Receptor is a Target for Neuroprotection in Light Induced Retinal Degeneration. Adv Drug Alcohol Res 2022;2:10734.
      doi: 10.3389/adar.2022.10734pubmed: 38390616google scholar: lookup
    9. Hirose S, Wang S, Jaggi U, Matundan HH, Kato M, Song XY, Molesworth-Kenyon SJ, Lausch RN, Ghiasi H. IL-17A expression by both T cells and non-T cells contribute to HSV-IL-2-induced CNS demyelination. Front Immunol 2023;14:1102486.
      doi: 10.3389/fimmu.2023.1102486pubmed: 36817487google scholar: lookup
    10. Karamali F, Behtaj S, Babaei-Abraki S, Hadady H, Atefi A, Savoj S, Soroushzadeh S, Najafian S, Nasr Esfahani MH, Klassen H. Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision. J Transl Med 2022 Dec 7;20(1):572.
      doi: 10.1186/s12967-022-03738-4pubmed: 36476500google scholar: lookup
    11. Zhou P, Xu Y, Yang L, Meng P, Guo J, Liu Z, Jin B, Xie K, Zhu H, Du L, Jin X. Insm1 promotes differentiation of retinal progenitor cells toward photoreceptor cells in the developing retina through up-regulation of SHH. J Mol Histol 2022 Dec;53(6):947-954.
      doi: 10.1007/s10735-022-10103-8pubmed: 36260151google scholar: lookup
    12. Caridi B, Doncheva D, Sivaprasad S, Turowski P. Galectins in the Pathogenesis of Common Retinal Disease. Front Pharmacol 2021;12:687495.
      doi: 10.3389/fphar.2021.687495pubmed: 34079467google scholar: lookup
    13. Tan SW, Cai GQ, Li QY, Guo Y, Pan YC, Zhang LJ, Ge QM, Shu HY, Zeng XJ, Shao Y. Interhemispheric Functional Connectivity Alterations in Diabetic Optic Neuropathy: A Resting-State Functional Magnetic Resonance Imaging Study. Diabetes Metab Syndr Obes 2021;14:2077-2086.
      doi: 10.2147/DMSO.S303782pubmed: 34007194google scholar: lookup
    14. Shin T, Ahn M, Kim J, Jung K, Moon C, Kim MD. Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review. Mol Neurobiol 2021 Jul;58(7):3484-3493.
      doi: 10.1007/s12035-021-02355-4pubmed: 33745114google scholar: lookup
    15. Jain N, Verma A, Jain N. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv 2020 Dec;27(1):888-899.
      doi: 10.1080/10717544.2020.1775726pubmed: 32551978google scholar: lookup
    16. Schlüter A, Aksan B, Diem R, Fairless R, Mauceri D. VEGFD Protects Retinal Ganglion Cells and, consequently, Capillaries against Excitotoxic Injury. Mol Ther Methods Clin Dev 2020 Jun 12;17:281-299.
      doi: 10.1016/j.omtm.2019.12.009pubmed: 32055648google scholar: lookup
    17. Nimmagadda K, Weiland JD. Retinotopic Responses in the Visual Cortex Elicited by Epiretinal Electrical Stimulation in Normal and Retinal Degenerate Rats. Transl Vis Sci Technol 2018 Sep;7(5):33.
      doi: 10.1167/tvst.7.5.33pubmed: 30402340google scholar: lookup
    18. Soliño M, López EM, Rey-Funes M, Loidl CF, Larrayoz IM, Martínez A, Girardi E, López-Costa JJ. Adenosine A1 receptor: A neuroprotective target in light induced retinal degeneration. PLoS One 2018;13(6):e0198838.
      doi: 10.1371/journal.pone.0198838pubmed: 29912966google scholar: lookup
    19. Wang Y, Zhang D, Zhang Y, Ni N, Tang Z, Bai Z, Shen B, Sun H, Gu P. Insulin-like growth factor-1 regulation of retinal progenitor cell proliferation and differentiation. Cell Cycle 2018;17(4):515-526.
      doi: 10.1080/15384101.2018.1431594pubmed: 29417866google scholar: lookup
    20. Zhang D, Shen B, Zhang Y, Ni N, Wang Y, Fan X, Sun H, Gu P. Betacellulin regulates the proliferation and differentiation of retinal progenitor cells in vitro. J Cell Mol Med 2018 Jan;22(1):330-345.
      doi: 10.1111/jcmm.13321pubmed: 28922560google scholar: lookup
    21. Singh R, Rajaraman S, Balasubramanian M. A Novel Nanoparticle Mediated Selective Inner Retinal Photocoagulation for Diseases of the Inner Retina. IEEE Trans Nanobioscience 2017 Oct;16(7):542-554.
      doi: 10.1109/TNB.2017.2741490pubmed: 28829313google scholar: lookup
    22. Lee DH, Zandian M, Kuo J, Mott KR, Chen S, Arditi M, Ghiasi H. Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice. PLoS Pathog 2017 May;13(5):e1006401.
      doi: 10.1371/journal.ppat.1006401pubmed: 28542613google scholar: lookup
    23. Nafissi N, Foldvari M. Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools. Front Neurosci 2015;9:355.
      doi: 10.3389/fnins.2015.00355pubmed: 26528114google scholar: lookup
    24. Zhang D, Ni N, Chen J, Yao Q, Shen B, Zhang Y, Zhu M, Wang Z, Ruan J, Wang J, Mo X, Shi W, Ji J, Fan X, Gu P. Electrospun SF/PLCL nanofibrous membrane: a potential scaffold for retinal progenitor cell proliferation and differentiation. Sci Rep 2015 Sep 23;5:14326.
      doi: 10.1038/srep14326pubmed: 26395224google scholar: lookup
    25. Maghami MH, Sodagar AM, Lashay A, Riazi-Esfahani H, Riazi-Esfahani M. Visual prostheses: the enabling technology to give sight to the blind. J Ophthalmic Vis Res 2014 Oct-Dec;9(4):494-505.
      doi: 10.4103/2008-322X.150830pubmed: 25709777google scholar: lookup
    26. Wang H, Zhang C, Lu D, Shu X, Zhu L, Qi R, So KF, Lu D, Xu Y. Oligomeric proanthocyanidin protects retinal ganglion cells against oxidative stress-induced apoptosis. Neural Regen Res 2013 Sep 5;8(25):2317-26.
      doi: 10.3969/j.issn.1673-5374.2013.25.002pubmed: 25206541google scholar: lookup
    27. McHugh KJ, Saint-Geniez M, Tao SL. Topographical control of ocular cell types for tissue engineering. J Biomed Mater Res B Appl Biomater 2013 Nov;101(8):1571-84.
      doi: 10.1002/jbm.b.32968pubmed: 23744715google scholar: lookup
    28. Nadri S, Kazemi B, Eslaminejad MB, Yazdani S, Soleimani M. High yield of cells committed to the photoreceptor-like cells from conjunctiva mesenchymal stem cells on nanofibrous scaffolds. Mol Biol Rep 2013 Jun;40(6):3883-90.
      doi: 10.1007/s11033-012-2360-ypubmed: 23588957google scholar: lookup
    29. Adamus G, Brown L, Andrew S, Meza-Romero R, Burrows GG, Vandenbark AA. Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice. Invest Ophthalmol Vis Sci 2012 Jan 25;53(1):406-12.
      doi: 10.1167/iovs.11-8419pubmed: 22167100google scholar: lookup
    30. Hein TW, Ren Y, Potts LB, Yuan Z, Kuo E, Rosa RH Jr, Kuo L. Acute retinal ischemia inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 2012 Jan 3;53(1):30-6.
      doi: 10.1167/iovs.11-8753pubmed: 22110081google scholar: lookup
    31. Chen H, Fan X, Xia J, Chen P, Zhou X, Huang J, Yu J, Gu P. Electrospun chitosan-graft-poly (ɛ-caprolactone)/poly (ɛ-caprolactone) nanofibrous scaffolds for retinal tissue engineering. Int J Nanomedicine 2011;6:453-61.
      doi: 10.2147/IJN.S17057pubmed: 21499434google scholar: lookup
    32. Gillig PM, Sanders RD. Cranial Nerve II: Vision. Psychiatry (Edgmont) 2009 Sep;6(9):32-7.
      pubmed: 19855858
    33. Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, Klassen H, Langer R, Young MJ. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials 2009 Jul;30(20):3405-14.
      doi: 10.1016/j.biomaterials.2009.02.046pubmed: 19361860google scholar: lookup
    34. Cho JH, Mu X, Wang SW, Klein WH. Retinal ganglion cell death and optic nerve degeneration by genetic ablation in adult mice. Exp Eye Res 2009 Mar;88(3):542-52.
      doi: 10.1016/j.exer.2008.11.021pubmed: 19109949google scholar: lookup
    35. de Balthasar C, Patel S, Roy A, Freda R, Greenwald S, Horsager A, Mahadevappa M, Yanai D, McMahon MJ, Humayun MS, Greenberg RJ, Weiland JD, Fine I. Factors affecting perceptual thresholds in epiretinal prostheses. Invest Ophthalmol Vis Sci 2008 Jun;49(6):2303-14.
      doi: 10.1167/iovs.07-0696pubmed: 18515576google scholar: lookup
    36. Neeley WL, Redenti S, Klassen H, Tao S, Desai T, Young MJ, Langer R. A microfabricated scaffold for retinal progenitor cell grafting. Biomaterials 2008 Feb;29(4):418-26.
      doi: 10.1016/j.biomaterials.2007.10.007pubmed: 17961646google scholar: lookup
    37. Chan A, Duker JS, Ishikawa H, Ko TH, Schuman JS, Fujimoto JG. Quantification of photoreceptor layer thickness in normal eyes using optical coherence tomography. Retina 2006 Jul-Aug;26(6):655-60.
      doi: 10.1097/01.iae.0000236468.33325.74pubmed: 16829808google scholar: lookup
    38. Harris JR, Brown GA, Jorgensen M, Kaushal S, Ellis EA, Grant MB, Scott EW. Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury. Invest Ophthalmol Vis Sci 2006 May;47(5):2108-13.
      doi: 10.1167/iovs.05-0928pubmed: 16639022google scholar: lookup
    Subscribe to our newsletter
    Join 99,000 horse owners like you who receive our email updates on horse health and nutrition.